Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydros and Hydros-TA for Knee Osteoarthritis Pain
NCT02022930Phase 3Completed
- Sponsor
- Carbylan Therapeutics
- Start
- Jan 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of hyaluronic acid + triamcinolone acetonide in osteoarthritis (OA), sponsored by Carbylan Therapeutics. Started Jan 2014; status: completed.
02
Drugs
hyaluronic acid + triamcinolone acetonide
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02022930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02022930.